Foto del docente

Giorgio Aicardi

Alma Mater Professor

Alma Mater Studiorum - Università di Bologna

Adjunct professor

Department for Life Quality Studies

Curriculum vitae

Giorgio Aicardi - short C.V.

1979: Degree in Pharmacy, full marks and honors, University of Bologna, Italy (Thesis Supervisor: Prof. Carlo Alfonso Rossi).

1981: Specialization in Applied Pharmacology, full marks and honors, University of Modena, Italy (Thesis Supervisor: Prof. Giorgio Cantelli Forti).

1979-1982: Postdoctoral Fellow, Institute of Pharmacology, University of Bologna, Italy. Research: mutagenicity, antimicrobial activity, structure-activity relationship (Supervisors: Prof. Gian Luigi Biagi and Prof. Giorgio Cantelli Forti).

1979-1980: Postdoctoral Fellow for 4 months (Italian National Research Council - British Council Fellowship) at the Department of Chemistry and Molecular Sciences, Warwick University, Coventry, U.K.). Research: heart mitochondrial respiration (Supervisor: Prof. David A. Griffiths).

1983-1992: Assistant Professor, General Physiology, Faculty of Pharmacy/Institute of Human Physiology, University of Bologna, Italy. Research: visual system (Supervisor: Prof. Claudio Galletti), motor system and sensory-motor integration (Supervisor: Prof. Carmela Rapisarda).

1988: Postdoctoral Fellow (N.A.T.O. - Italian National Research Council fellowship) for 12 months at the Department of Neurological Surgery, University of Washington, Seattle, WA, U.S.A.. Research: electrophysiology in hippocampal slices, calcium channels, epilepsy (Supervisor: Prof. Philip A. Schwartzkroin).

1992-2017: Associate Professor of General Physiology; Faculty of Pharmacy/Department of Human and General Physiology (1992-2012); School of Pharmacy, Biotechnology and Sport Sciences/Department for Life Quality Studies (2012-present), University of Bologna, Italy.

1993-2025: Principal Investigator of the research group: "Neurophysiology, Cellular Physiology and Biophysics" at the Department of Human and General Physiology (2012-present: Principal Investigator of the research group “Neurophysiology” at the Department for Life Quality Studies), University of Bologna, Italy. Research: modulation of voltage-gated ion channels; effect of electromagnetic fields on nervous cells; synaptic plasticity, learning and memory, brain aging; neurophysiology of drug addiction.

2006-2009: Vice-Director of the Department of Human and General Physiology, University of Bologna, Italy.

2007-2009: Vice-President of the Degree Course “Pharmacy”, Faculty of Pharmacy/School of Pharmacy, Biotechnology and Sport Sciences, University of Bologna, Italy.

2009-2015: President/Coordinator of the Degree Course “Quality Control of Health Products”, Faculty of Pharmacy/School of Pharmacy, Biotechnology and Sport Sciences, University of Bologna, Italy.

2009-2010: Collaboration for 2 months with Prof. Leon N. Cooper (Nobel Laureate, Physics) at the Institute for Brain and Neural Systems, Brown University, Providence, RI, U.S.A.. Research: bistability in synaptic plasticity, BMC theory.

2012-2022: Member of the World Health Organization Team of Experts (Working Group on in vitro studies, and Working Group on in vivo animal studies) for "Health risk assessment of radiofrequency electromagnetic fields".

2014: Qualified for the position of Full Professor of Physiology.

2017-2025: Full Professor of Physiology, Department for Life Quality Studies, University of Bologna, Italy.

2017-present: Contract Professor of Physiology, Department for Life Quality Studies, University of Bologna, Italy.

He obtained funding for his research from various Institutions, including the European Union, the Italian Ministry of University and Research (FIRB and PRIN projects), the National Research Council, the Monte di Bologna and Ravenna Foundation and the Carisbo Foundation from Bologna.

Until October 2025, he coordinated the Research Unit (in which he still works) of the University of Bologna of the GOLIAT project (5G exOsure, causaL effects, and RIsk perception through citizen engAgemenT), aimed to monitor radiofrequency electromagnetic fields exposure, particularly from 5G, provide novel insights into its potential causal health effects, and understand how exposures and risks are perceived and best communicated using citizen engagement. The project has a duration of 5 years (1 June 2022 - 31 May 2027) and a total funding of 9.3 million euros, 7 of which have been provided by the European Union (HORIZON-HLTH-2021-ENVHLTH-02, Grant Agreement no. 101057262).

Moreover, until October 2025 he coordinated the Research Unit (in which he still works) of the University of Bologna of the project 5G:SMILE (5G technology: bridging in vitro and in Silico Models to Investigate the interaction mechanisms at cellular LEvel) funded by MUR (PRIN 2022).

Updated list of peer-reviewed publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=aicardi+g